25 May 2013
Keywords: exjade, cuts, thalassemia, iron, build, up, organs
Article | 20 October 2008
Interim study results show that Novartis' once-daily Exjade (deferasirox) reduces iron build-up in key organs in patients who
undergo repeated ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 October 2008
27 October 2008
24 May 2013
© 2013 thepharmaletter.com